Details
Stereochemistry | ACHIRAL |
Molecular Formula | 3C15H17O3S.3Na.H2O |
Molecular Weight | 919.061 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[Na+].[Na+].[Na+].CCC1=CC(=C2C=C(C=CC=C12)C(C)C)S([O-])(=O)=O.CCC3=CC(=C4C=C(C=CC=C34)C(C)C)S([O-])(=O)=O.CCC5=CC(=C6C=C(C=CC=C56)C(C)C)S([O-])(=O)=O
InChI
InChIKey=NLAZKIKOGLLKFO-UHFFFAOYSA-K
InChI=1S/3C15H18O3S.3Na.H2O/c3*1-4-11-9-15(19(16,17)18)14-8-12(10(2)3)6-5-7-13(11)14;;;;/h3*5-10H,4H2,1-3H3,(H,16,17,18);;;;1H2/q;;;3*+1;/p-3
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/23568973
Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973
Egualen is an azulene derivative developed for the treatment of peptic ulcer and marketed in Japan under the tradename Azuloxa. The drug exerts its antiulcer activity by antagonizing TXA2 production.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0038193 Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973 |
|||
Target ID: GO:1990768 Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973 |
|||
Target ID: GO:0070254 Sources: http://www.ncbi.nlm.nih.gov/pubmed/23568973 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | AZULOXA Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Inhibitory effect of egualen sodium: a new stable derivative of azulene on histamine release from mast cell-like cells in the stomach. | 2001 |
|
A ring expansion-annulation strategy for the synthesis of substituted azulenes. Preparation and Suzuki coupling reactions of 1-azulenyl triflates. | 2001 Apr 5 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
249501B040
Created by
admin on Sat Dec 16 05:22:47 GMT 2023 , Edited by admin on Sat Dec 16 05:22:47 GMT 2023
|
PRIMARY | |||
|
11954341
Created by
admin on Sat Dec 16 05:22:47 GMT 2023 , Edited by admin on Sat Dec 16 05:22:47 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD